Answers are grounded in this paper and cite their sources.
SUMMARY The prophylactic perioperative use of antifibrinolytics in open‐heart surgery substantially reduces hemorrhage and allogeneic blood requirements. This has been proven for open‐heart surgery, but is not as evident for other surgical procedures. In general, the higher the degree of intraoperative hemostatic activation, the more effective in terms of decreased bleeding tendency a pharmacological antifibrinolytic intervention will be. It should be emphasized that aprotinin, in contrast to tranexamic acid or epsilon aminocaproic acid, does not act as a pure antifibrinolytic, but also has thrombin‐reducing properties. Promising results for aprotinin as an antiinflammatory agent are under discussion. Both drugs are recommended for the reduction of bleeding tendency during and after open‐heart surgery. Review of the literature suggests the routine use of antifibrinolytics during open‐heart surgery.
No takes yet. Share an insight, caveat, or question.
Wulf Dietrich (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: